Tag: lumpectomy

Articles

• Ductal carcinoma in situ (DCIS) prognosis
• Morphine during surgery might increase risk of metastasis

News

03/31/18

Ideal time between surgery & radiotherapy after neoadjuvant chemo

07/04/16

Radiotherapy after lumpectomy improves survival in older ER- women

12/06/15

Heavily treated DCIS less likely to progress in the long term

06/02/15

Local recurrence rates for LCIS can be significant

03/09/14

Reconstruction using fat stem cells could promote TN metastasis

01/12/14

Almost 1-in-3 relapse if no radiation after lumpectomy for DCIS

03/13/13

Radiotherapy significantly reduces recurrence in women with DCIS

01/31/13

Radiation treatment improves survival in women with dense breasts

06/13/12

It's too early to regrow breasts using fat stem cells

03/19/12

Risk of DCIS relapse or progression continues at least 20 years

12/04/11

Lumpectomy vs. mastectomy rates vary by type of breast cancer

10/22/11

Young breast cancer patients require aggressive treatment

10/21/11

Radiotherapy after lumpectomy reduces long-term recurrence

10/20/11

Age and breast cancer subtype influence prognosis after lumpectomy

03/17/11

Radiation after lumpectomy reduces recurrence for DCIS survivors

11/04/10

MRIs find additional disease in 20% of lobular BC patients

10/03/10

Lobular breast cancer micrometastases may be classified incorrectly

09/08/10

Sentinel node micrometastases do not reduce breast cancer survival

03/22/10

Breast reduction surgery may be combined with lumpectomy for DCIS

03/04/10

Delay in radiotherapy increases risk of local recurrence

01/12/10

Risk of BC cell seeding varies according to needle biopsy method

Studies

• Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence Cite
  Fine RE, Gilmore RC, Tomkovich KR, Dietz JR, Berry MP, Hernandez LE, et al. Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2024; 10.1245/s10434-024-16181-0
• Radiotherapy is recommended for hormone receptor-negative older breast cancer patients after breast conserving surgery Cite
  Liu Y, Li J, Li H, Zhang G, Li C, Wei C, et al. Radiotherapy is recommended for hormone receptor-negative older breast cancer patients after breast conserving surgery. Scientific Reports. Springer Science and Business Media LLC; 2024; 14 10.1038/s41598-024-66401-6
• Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma in situ: observational cohort study Cite
  Wang SM, Li Y, Nash A, Ren Y, Thomas SM, Francescatti AB, et al. Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma in situ: observational cohort study. British Journal of Surgery. Oxford University Press (OUP); 2024; 111 10.1093/bjs/znae198
• Survival outcomes after breast cancer surgery among older women with early invasive breast cancer in England: population-based cohort study Cite
  Miller K, Gannon MR, Medina J, Clements K, Dodwell D, Horgan K, et al. Survival outcomes after breast cancer surgery among older women with early invasive breast cancer in England: population-based cohort study. BJS Open. Oxford University Press (OUP); 2024; 8 10.1093/bjsopen/zrae062
• Lumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 study Cite
  Wright JL, Gray R, Rahbar H, Comstock CE, Tjoe JA, Badve S, et al. Lumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 study. npj Breast Cancer. Springer Science and Business Media LLC; 2024; 10 10.1038/s41523-024-00622-w
• Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery? Cite
  van de Loo ME, Andour L, van Heesewijk AE, Oosterkamp HM, Liefers G, Straver ME. Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery?. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-023-07222-5
• Outcomes of Breast-Conserving Therapy in Patients With Inflammatory Breast Cancer: A Meta-Analysis Cite
  Lai H, Loh E, Su C, Chiang M, Tam K. Outcomes of Breast-Conserving Therapy in Patients With Inflammatory Breast Cancer: A Meta-Analysis. Journal of Surgical Research. Elsevier BV; 2024; 293:458-467 10.1016/j.jss.2023.08.047
• Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer Cite
  Whelan TJ, Smith S, Parpia S, Fyles AW, Bane A, Liu F, et al. Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer. New England Journal of Medicine. Massachusetts Medical Society; 2023; 389:612-619 10.1056/nejmoa2302344
• Abstract P1-09-11: Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer: mastectomy versus conservative treatment Cite
  JANKOWSKI C, Mahiou K, Laura V, Costaz H, padéano M, Causeret S, et al. Abstract P1-09-11: Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer: mastectomy versus conservative treatment. Cancer Research. American Association for Cancer Research (AACR); 2023; 83:P1-09-11-P1-09-11 10.1158/1538-7445.sabcs22-p1-09-11
• Surgical management of BRCA-mutation carriers: A single institution experience Cite
  Gentile D, Losurdo A, Sagona A, Zuradelli M, Gatzemeier W, Barbieri E, et al. Surgical management of BRCA-mutation carriers: A single institution experience. European Journal of Surgical Oncology. Elsevier BV; 2022; 48:1706-1712 10.1016/j.ejso.2022.04.024
• Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery Cite
  Orozco JIJ, Keller JK, Chang S, Fancher CE, Grumley JG. Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 10.1245/s10434-022-12190-z
• The Use of Pectoralis Blocks in Breast Surgery: A Practice Advisory and Narrative Review from the Society for Ambulatory Anesthesia (SAMBA) Cite
  Ardon AE, George JE, Gupta K, O’Rourke MJ, Seering MS, Tokita HK, et al. The Use of Pectoralis Blocks in Breast Surgery: A Practice Advisory and Narrative Review from the Society for Ambulatory Anesthesia (SAMBA). Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 29:4777-4786 10.1245/s10434-022-11724-9
• Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS Cite
  Nakhlis F, Katlin FD, Grossmith SC, DiPasquale A, Harrison BT, Schnitt SJ, et al. Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 10.1245/s10434-022-12066-2
• Abstract P3-18-03: Long-term outcomes for breast conservation plus radiotherapy versus mastectomy in early breast cancer after neoadjuvant systemic therapy: Results from the Swedish national breast cancer register (NKBC) Cite
  Wang K, Duinmeijer A, Matikas A, Altena R, Johansson H, Fredholm H, et al. Abstract P3-18-03: Long-term outcomes for breast conservation plus radiotherapy versus mastectomy in early breast cancer after neoadjuvant systemic therapy: Results from the Swedish national breast cancer register (NKBC). Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P3-18-03-P3-18-03 10.1158/1538-7445.sabcs21-p3-18-03
• Abstract P3-18-02: Breast conservation plus radiotherapy provides superior survival benefit than mastectomy in triple negative breast cancer: A propensity matched national cancer database analysis Cite
  Cao L, Towe CW, Miller ME, Montero AJ, Shenk R. Abstract P3-18-02: Breast conservation plus radiotherapy provides superior survival benefit than mastectomy in triple negative breast cancer: A propensity matched national cancer database analysis. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P3-18-02-P3-18-02 10.1158/1538-7445.sabcs21-p3-18-02
• Abstract P1-24-05: Breast conserving surgery for non-metastatic inflammatory breast cancer: A National Cancer Database (NCDB) study Cite
  Angarita FA, Edge SB, Attwood K, Takabe K, Young J. Abstract P1-24-05: Breast conserving surgery for non-metastatic inflammatory breast cancer: A National Cancer Database (NCDB) study. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P1-24-05-P1-24-05 10.1158/1538-7445.sabcs21-p1-24-05
• Oncological Safety of Oncoplastic Level II Mammoplasties After Neoadjuvant Chemotherapy for Large Breast Cancers: A Matched-Cohort Analysis Cite
  van la Parra RFD, Clough KB, Thygesen HH, Levy E, Poulet B, Sarfati I, et al. Oncological Safety of Oncoplastic Level II Mammoplasties After Neoadjuvant Chemotherapy for Large Breast Cancers: A Matched-Cohort Analysis. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 28:5920-5928 10.1245/s10434-021-09829-8
• Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy? Cite
  Guo L, Xie G, Wang R, Yang L, Sun L, Xu M, et al. Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy?. BMC Cancer. Springer Science and Business Media LLC; 2021; 21 10.1186/s12885-021-08429-9
• Effects of Adjuvant Endocrine Therapy Adherence and Radiation on Recurrence and Survival Among Older Women with Early-Stage Breast Cancer Cite
  Showalter SL, Meneveau MO, Keim-Malpass J, Camacho TF, Squeo G, Anderson RT. Effects of Adjuvant Endocrine Therapy Adherence and Radiation on Recurrence and Survival Among Older Women with Early-Stage Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 10.1245/s10434-021-10064-4
• Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status Cite
  de Boniface J, Szulkin R, Johansson ALV. Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status. JAMA Surgery. American Medical Association (AMA); 2021; 10.1001/jamasurg.2021.1438
• Title: Weight and waist-to-hip ratio change pattern during the first five years of survival: data from a longitudinal observational Chinese breast cancer cohort Cite
  Lei Y, Ho SC, Kwok C, Cheng A, Cheung KL, Lee R, et al. Title: Weight and waist-to-hip ratio change pattern during the first five years of survival: data from a longitudinal observational Chinese breast cancer cohort. Research Square; 2021; 10.21203/rs.3.rs-250564/v1
• Long-term survival comparison of repeated breast conserving surgery vs. mastectomy for DCIS patients with ipsilateral breast tumor recurrence: A real-world longitudinal study Cite
  Li Q, Wang K, Yang L, Wu Q, Zhu W, Li Z, et al. Long-term survival comparison of repeated breast conserving surgery vs. mastectomy for DCIS patients with ipsilateral breast tumor recurrence: A real-world longitudinal study. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.02.012
• Local Recurrence in Young Women with Breast Cancer: Breast Conserving Therapy vs. Mastectomy Alone Cite
  Nguyen DV, Kim S, Oh Y, Noh OK, Jung Y, Yoon DS, et al. Local Recurrence in Young Women with Breast Cancer: Breast Conserving Therapy vs. Mastectomy Alone. Research Square; 2021; 10.21203/rs.3.rs-209244/v1
• How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery? Cite
  Petruolo O, Sevilimedu V, Montagna G, Le T, Morrow M, Barrio AV. How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 28:287-294 10.1245/s10434-020-08593-5
• Is Autologous Fat Grafting an Oncologically Safe Procedure following Breast Conserving Surgery for Breast Cancer? A Comprehensive Review Cite
  Tayeh S, Muktar S, Wazir U, Carmichael A, Al-Fardan Z, Kasem A, et al. Is Autologous Fat Grafting an Oncologically Safe Procedure following Breast Conserving Surgery for Breast Cancer? A Comprehensive Review. Journal of Investigative Surgery. Informa UK Limited; 2020;:1-10 10.1080/08941939.2020.1852343
• The Role of Radiation Therapy in Addition to Lumpectomy and Hormone Therapy in Men 70 Years of Age and Older with Early Breast Cancer: A NCDB Analysis Cite
  Bateni SB, Perry LM, Zhao X, Arora M, Daly ME, Stewart SL, et al. The Role of Radiation Therapy in Addition to Lumpectomy and Hormone Therapy in Men 70 Years of Age and Older with Early Breast Cancer: A NCDB Analysis. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 10.1245/s10434-020-09242-7
• Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study Cite
  Simons JM, Jacobs JG, Roijers JP, Beek MA, Boonman-de Winter LJM, Rijken AM, et al. Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05966-y
• Oncoplastic breast surgery combining partial mastectomy with V-rotation mammoplasty for breast cancer on the upper inner area of the breast Cite
  Kijima Y, Hirata M, Higo N, Toda H. Oncoplastic breast surgery combining partial mastectomy with V-rotation mammoplasty for breast cancer on the upper inner area of the breast. Surgery Today. Springer Science and Business Media LLC; 2020; 10.1007/s00595-020-02152-x
• Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study Cite
  Joseph K, Zebak S, Alba V, Mah K, Au C, Vos L, et al. Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study. Radiotherapy and Oncology. Elsevier BV; 2020; 154:93-100 10.1016/j.radonc.2020.09.017
• Radiotherapy after breast‐conserving surgery for elderly patients with early‐stage breast cancer: A national registry‐based study Cite
  Wang F, Meszoely I, Pal T, Mayer IA, Bailey CE, Zheng W, et al. Radiotherapy after breast‐conserving surgery for elderly patients with early‐stage breast cancer: A national registry‐based study. International Journal of Cancer. Wiley; 2020; 148:857-867 10.1002/ijc.33265
• The effect of omission of adjuvant radiotherapy after neoadjuvant chemotherapy and breast conserving surgery with a pathologic complete response Cite
  Mandish SF, Gaskins JT, Yusuf MB, Amer YM, Eldredge-Hindy H. The effect of omission of adjuvant radiotherapy after neoadjuvant chemotherapy and breast conserving surgery with a pathologic complete response. Acta Oncologica. Informa UK Limited; 2020; 59:1210-1217 10.1080/0284186x.2020.1797161
• The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiotherapy Cite
  Escott CE, Zaenger D, Switchencko JM, Lin JY, Abugideiri M, Arciero CA, et al. The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiotherapy. Clinical Breast Cancer. Elsevier BV; 2020; 20:e701-e710 10.1016/j.clbc.2020.05.007
• Radiation and/or endocrine therapy? Recurrence and survival outcomes in women over 70 with early breast cancer after breast-conserving surgery Cite
  Dahn H, Wilke D, Walsh G, Pignol J. Radiation and/or endocrine therapy? Recurrence and survival outcomes in women over 70 with early breast cancer after breast-conserving surgery. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 182:411-420 10.1007/s10549-020-05691-6
• Lumpectomy Margins for Invasive Breast Cancer and Ductal Carcinoma in Situ: Current Guideline Recommendations, Their Implications, and Impact Cite
  Schnitt SJ, Moran MS, Giuliano AE. Lumpectomy Margins for Invasive Breast Cancer and Ductal Carcinoma in Situ: Current Guideline Recommendations, Their Implications, and Impact. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:2240-2245 10.1200/jco.19.03213
• Radiation therapy following breast conserving surgery (BCS) in women with early-stage breast cancer and low oncotype scores. Cite
  Damico N, Kharouta M, Lyons JA, Harris EE. Radiation therapy following breast conserving surgery (BCS) in women with early-stage breast cancer and low oncotype scores.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:e12547-e12547 10.1200/jco.2020.38.15_suppl.e12547
• Breast conservation therapy confers survival and distant recurrence advantage over mastectomy for stage II Triple Negative Breast cancer Cite
  Macfie R, Aks C, Panwala K, Johnson N, Jennifer Garreau . Breast conservation therapy confers survival and distant recurrence advantage over mastectomy for stage II Triple Negative Breast cancer. The American Journal of Surgery. Elsevier BV; 2020; 10.1016/j.amjsurg.2020.04.016
• Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review Cite
  Sauder CA, Bateni SB, Davidson AJ, Nishijima DK. Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review. Clinical Breast Cancer. Elsevier BV; 2020; 20:e309-e314 10.1016/j.clbc.2019.12.004
• Long-term Results After Neoadjuvant Chemotherapy for Breast Cancer: A Single-center Experience Cite
  GIANI M, RENDA I, VALLARIO A, TAVELLA K, VILLANUCCI A, NORI J, et al. Long-term Results After Neoadjuvant Chemotherapy for Breast Cancer: A Single-center Experience. Anticancer Research. Anticancer Research USA Inc.; 2020; 40:1079-1085 10.21873/anticanres.14046
• Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review Cite
  Sauder CA, Bateni SB, Davidson AJ, Nishijima DK. Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review. Clinical Breast Cancer. Elsevier BV; 2020; 20:e309-e314 10.1016/j.clbc.2019.12.004
• Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ Cite
  Hung P, Wang S, Killelea BK, Mougalian SS, Evans SB, Sedghi T, et al. Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ. JNCI Cancer Spectrum. Oxford University Press (OUP); 2019; 3 10.1093/jncics/pkz052
• Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence Cite
  Su Y, Guo R, Xue J, Chi Y, Chi W, Wang J, et al. Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence. The Oncologist. Wiley; 2019; 24 10.1634/theoncologist.2018-0606
• Breast-conserving surgery without radiation in elderly women with early breast cancer Cite
  Inoue H, Hirano A, Ogura K, Kamimura M, Hattori A, Yukawa H, et al. Breast-conserving surgery without radiation in elderly women with early breast cancer. Surgical Oncology. Elsevier BV; 2019; 31:22-25 10.1016/j.suronc.2019.08.008
• Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor–Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database Cite
  Buszek SM, Lin HY, Bedrosian I, Tamirisa N, Babiera GV, Shen Y, et al. Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor–Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2019; 105:795-802 10.1016/j.ijrobp.2019.07.052
• Oncologic Results of Breast Conserving Surgery under Procedural Sedation in Elderly Patients Cite
  Lee J, Jung JH, Kim WW, Lim YS, Lee RK, Kwak K, et al. Oncologic Results of Breast Conserving Surgery under Procedural Sedation in Elderly Patients. Journal of Breast Disease. Korean Breast Cancer Society; 2019; 7:9-15 10.14449/jbd.2019.7.1.9
• Breast-Conserving Therapy is Associated with Improved Survival Compared with Mastectomy for Early-Stage Breast Cancer: A Propensity Score Matched Comparison Using the National Cancer Database Cite
  Wrubel E, Natwick R, Wright GP. Breast-Conserving Therapy is Associated with Improved Survival Compared with Mastectomy for Early-Stage Breast Cancer: A Propensity Score Matched Comparison Using the National Cancer Database. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 10.1245/s10434-020-08829-4
• Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis Cite
  Bateni SB, Davidson AJ, Arora M, Daly ME, Stewart SL, Bold RJ, et al. Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2019; 26:2144-2153 10.1245/s10434-019-07159-4
• Abstract P6-19-06: Breast conservation surgery in male breast cancer: A systematic literature review Cite
  Fisher C, de la Cruz L, Joshi S, Mah T, Blankenship S, Thiruchelvam P. Abstract P6-19-06: Breast conservation surgery in male breast cancer: A systematic literature review. Poster Session Abstracts. American Association for Cancer Research; 2019; 10.1158/1538-7445.sabcs18-p6-19-06
• Breast-conserving surgery for pure non-classic lobular carcinoma in situ: A single institution's experience Cite
  Hoffman DI, Zhang PJ, Tchou J. Breast-conserving surgery for pure non-classic lobular carcinoma in situ: A single institution's experience. Surgical Oncology. Elsevier BV; 2019; 28:190-194 10.1016/j.suronc.2019.01.009
• Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact Cite
  Houvenaeghel G, de Nonneville A, Cohen M, Classe J, Reyal F, Mazouni C, et al. Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 173:111-122 10.1007/s10549-018-4944-2
• Functional Status and Survival After Breast Cancer Surgery in Nursing Home Residents Cite
  Tang V, Zhao S, Boscardin J, Sudore R, Covinsky K, Walter LC, et al. Functional Status and Survival After Breast Cancer Surgery in Nursing Home Residents. JAMA Surgery. American Medical Association (AMA); 2018; 153:1090 10.1001/jamasurg.2018.2736
• Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy Cite
  Giannakeas V, Sopik V, Narod SA. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy. JAMA Network Open. American Medical Association (AMA); 2018; 1:e181100 10.1001/jamanetworkopen.2018.1100
• Survival following breast-conserving therapy is equal to that following mastectomy in young women with early-stage invasive lobular carcinoma Cite
  Yu T, Liu Y, Hu X, Di G. Survival following breast-conserving therapy is equal to that following mastectomy in young women with early-stage invasive lobular carcinoma. European Journal of Surgical Oncology. Elsevier BV; 2018; 44:1703-1707 10.1016/j.ejso.2018.06.026
• Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe Cite
  Wickberg Å, Liljegren G, Killander F, Lindman H, Bjöhle J, Carlberg M, et al. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe. European Journal of Surgical Oncology. Elsevier BV; 2018; 44:951-956 10.1016/j.ejso.2018.04.002
• Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Cite
  Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:561-564 10.1200/jco.2016.71.0947
• Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials Cite
  Asselain B, Barlow W, Bartlett J, Bergh J, Bergsten-Nordström E, Bliss J, et al. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. The Lancet Oncology. Elsevier BV; 2018; 19:27-39 10.1016/s1470-2045(17)30777-5
• Association between unilateral or bilateral mastectomy and breast cancer death in patients with unilateral ductal carcinoma Cite
  Agarwal S, Pappas L, Agarwal J. Association between unilateral or bilateral mastectomy and breast cancer death in patients with unilateral ductal carcinoma. Cancer Management and Research. Informa UK Limited; 2017; Volume 9:649-656 10.2147/cmar.s148456
• Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis Cite
  Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis. JAMA. American Medical Association (AMA); 2017; 318:918 10.1001/jama.2017.11470
• The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival Cite
  van Maaren MC, Bretveld RW, Jobsen JJ, Veenstra RK, Groothuis-Oudshoorn CG, Struikmans H, et al. The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival. British Journal of Cancer. Springer Science and Business Media LLC; 2017; 117:179-188 10.1038/bjc.2017.159
• Improved prognosis of young patients with breast cancer undergoing breast-conserving surgery Cite
  Botteri E, Veronesi P, Vila J, Rotmensz N, Galimberti V, Thomazini MV, et al. Improved prognosis of young patients with breast cancer undergoing breast-conserving surgery. British Journal of Surgery. Wiley; 2017; 104:1802-1810 10.1002/bjs.10658
• Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer Cite
  Maishman T, Cutress RI, Hernandez A, Gerty S, Copson ER, Durcan L, et al. Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer. Annals of Surgery. Ovid Technologies (Wolters Kluwer Health); 2017; 266:165-172 10.1097/sla.0000000000001930
• Breast-Conserving Surgery Alone for Ductal Carcinoma In Situ: Factors Associated with Increased Risk of Local Recurrence Cite
  Mele A, Mehta P, Slanetz PJ, Brook A, Recht A, Sharma R. Breast-Conserving Surgery Alone for Ductal Carcinoma In Situ: Factors Associated with Increased Risk of Local Recurrence. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2016; 24:1221-1226 10.1245/s10434-016-5711-4
• Breast-Conserving Surgery Under Local Anesthesia in Elderly Patients with Severe Cardiorespiratory Comorbidities: A Hospital-Based Case-Control Study Cite
  Karanlik H, Kılıç B, Yıldırım I, Bademler S, Ozgur I, Ilhan B, et al. Breast-Conserving Surgery Under Local Anesthesia in Elderly Patients with Severe Cardiorespiratory Comorbidities: A Hospital-Based Case-Control Study. Breast Care. S. Karger AG; 2017; 12:28-32 10.1159/000455003
• Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database Cite
  Landercasper J, Bennie B, Parsons BM, Dietrich LL, Greenberg CC, Wilke LG, et al. Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2017; 24:1507-1515 10.1245/s10434-016-5760-8
• The role of oncoplastic breast reduction in the conservative management of breast cancer: Complications, survival, and quality of life Cite
  Acea‐Nebril B, Cereijo‐Garea C, García‐Novoa A, Varela‐Lamas C, Builes‐Ramírez S, Bouzón‐Alejandro A, et al. The role of oncoplastic breast reduction in the conservative management of breast cancer: Complications, survival, and quality of life. Journal of Surgical Oncology. Wiley; 2017; 115:679-686 10.1002/jso.24550
• Survival after Breast-Conserving Surgery with Whole Breast or Partial Breast Irradiation in Women with Early Stage Breast Cancer: A SEER Data-base Analysis Cite
  Grover S, Nurkic S, Diener-West M, Showalter SL. Survival after Breast-Conserving Surgery with Whole Breast or Partial Breast Irradiation in Women with Early Stage Breast Cancer: A SEER Data-base Analysis. The Breast Journal. Wiley; 2016; 23:292-298 10.1111/tbj.12729
• Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy Cite
  van Roozendaal LM, Goorts B, Klinkert M, Keymeulen KBMI, De Vries B, Strobbe LJA, et al. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 156:517-525 10.1007/s10549-016-3783-2
• Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study Cite
  de Boniface J, Frisell J, Bergkvist L, Andersson Y. Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study. British Journal of Surgery. Oxford University Press (OUP); 2017; 104:238-247 10.1002/bjs.10411
• Hyperalgesia and Persistent Pain after Breast Cancer Surgery: A Prospective Randomized Controlled Trial with Perioperative COX-2 Inhibition Cite
  van Helmond N, Steegers MA, Filippini-de Moor GP, Vissers KC, Wilder-Smith OH. Hyperalgesia and Persistent Pain after Breast Cancer Surgery: A Prospective Randomized Controlled Trial with Perioperative COX-2 Inhibition. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0166601 10.1371/journal.pone.0166601
• Low risk of recurrence in elderly patients treated with breast conserving therapy in a single institute Cite
  van der Leij F, van Werkhoven E, Bosma S, Linn SC, Rutgers EJ, van de Vijver MJ, et al. Low risk of recurrence in elderly patients treated with breast conserving therapy in a single institute. The Breast. Elsevier BV; 2016; 30:19-25 10.1016/j.breast.2016.08.004
• Systematic review: The oncological safety of adipose fat transfer after breast cancer surgery Cite
  Waked K, Colle J, Doornaert M, Cocquyt V, Blondeel P. Systematic review: The oncological safety of adipose fat transfer after breast cancer surgery. The Breast. Elsevier BV; 2017; 31:128-136 10.1016/j.breast.2016.11.001
• Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy Cite
  Braunstein LZ, Taghian AG, Niemierko A, Salama L, Capuco A, Bellon JR, et al. Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 161:173-179 10.1007/s10549-016-4031-5
• The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance Cite
  Youssef MM, Cameron D, Pucher PH, Olsen S, Ferguson D. The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance. The Breast. Elsevier BV; 2016; 30:101-104 10.1016/j.breast.2016.09.005
• No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT Cite
  Killander F, Karlsson P, Anderson H, Mattsson J, Holmberg E, Lundstedt D, et al. No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT. European Journal of Cancer. Elsevier BV; 2016; 67:57-65 10.1016/j.ejca.2016.08.001
• Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger Cite
  Plichta JK, Rai U, Tang R, Coopey SB, Buckley JM, Gadd MA, et al. Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2016; 23:3212-3220 10.1245/s10434-016-5404-z
• 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study Cite
  van Maaren MC, de Munck L, de Bock GH, Jobsen JJ, van Dalen T, Linn SC, et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. The Lancet Oncology. Elsevier BV; 2016; 17:1158-1170 10.1016/s1470-2045(16)30067-5
• Benefit of adjuvant radiotherapy after breast-conserving therapy among elderly women with T1-T2N0 estrogen receptor-negative breast cancer Cite
  Eaton BR, Jiang R, Torres MA, Kahn ST, Godette K, Lash TL, et al. Benefit of adjuvant radiotherapy after breast-conserving therapy among elderly women with T1-T2N0 estrogen receptor-negative breast cancer. Cancer. Wiley; 2016; 122:3059-3068 10.1002/cncr.30142
• Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients Cite
  Laurberg T, Lyngholm CD, Christiansen P, Alsner J, Overgaard J. Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients. Radiotherapy and Oncology. Elsevier BV; 2016; 120:98-106 10.1016/j.radonc.2016.05.006
• Is Breast Conserving Therapy a Safe Modality for Early-Stage Male Breast Cancer? Cite
  Zaenger D, Rabatic BM, Dasher B, Mourad WF. Is Breast Conserving Therapy a Safe Modality for Early-Stage Male Breast Cancer?. Clinical Breast Cancer. Elsevier BV; 2016; 16:101-104 10.1016/j.clbc.2015.11.005
• Persistent Breast Pain Among Women With Histories of Breast-conserving Surgery for Breast Cancer Compared With Women Without Histories of Breast Surgery or Cancer Cite
  Edmond SN, Shelby RA, Keefe FJ, Fisher HM, Schmidt JE, Soo MS, et al. Persistent Breast Pain Among Women With Histories of Breast-conserving Surgery for Breast Cancer Compared With Women Without Histories of Breast Surgery or Cancer. The Clinical Journal of Pain. Ovid Technologies (Wolters Kluwer Health); 2017; 33:51-56 10.1097/ajp.0000000000000377
• Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period Cite
  Bosma SCJ, van der Leij F, van Werkhoven E, Bartelink H, Wesseling J, Linn S, et al. Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 156:391-400 10.1007/s10549-016-3732-0
• Triple Negative Breast Cancer versus Non-Triple Negative Breast Cancer Treated with Breast Conservation Surgery Followed by Radiotherapy: A Systematic Review and Meta-Analysis Cite
  Pan X, Qu S, Jiang Y, Zhu X. Triple Negative Breast Cancer versus Non-Triple Negative Breast Cancer Treated with Breast Conservation Surgery Followed by Radiotherapy: A Systematic Review and Meta-Analysis. Breast Care. S. Karger AG; 2015; 10:413-416 10.1159/000441436
• Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis Cite
  Yoshida A, Takahashi O, Okumura Y, Arima N, Nakatsukasa K, Tanabe M, et al. Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2016; 42:474-480 10.1016/j.ejso.2016.01.011
• Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics Cite
  Hofvind S, Holen Å, Aas T, Roman M, Sebuødegård S, Akslen L. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2015; 41:1417-1422 10.1016/j.ejso.2015.07.002
• Breast conservation after neoadjuvant therapy for tumors ≥5 cm: A prospective cohort study Cite
  Libson S, Koshenkov V, Rodgers S, Hurley J, Avisar E. Breast conservation after neoadjuvant therapy for tumors ≥5 cm: A prospective cohort study. International Journal of Surgery Open. Elsevier BV; 2015; 1:10-13 10.1016/j.ijso.2015.12.001
• Oncoplastic reduction mammoplasty for breast cancer in women with macromastia: Oncological long-term outcomes Cite
  Emiroglu M, Salimoglu S, Karaali C, Sert I, Gungor O, Sert F, et al. Oncoplastic reduction mammoplasty for breast cancer in women with macromastia: Oncological long-term outcomes. Asian Journal of Surgery. Elsevier BV; 2017; 40:41-47 10.1016/j.asjsur.2015.07.007
• A comparison of three different radiotherapy boost techniques after breast conserving therapy for breast cancer Cite
  Verhoeven K, Kindts I, Laenen A, Peeters S, Janssen H, Van Limbergen E, et al. A comparison of three different radiotherapy boost techniques after breast conserving therapy for breast cancer. The Breast. Elsevier BV; 2015; 24:391-396 10.1016/j.breast.2015.03.003
• No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study Cite
  Nordenskjöld A, Fohlin H, Albertsson P, Arnesson L, Chamalidou C, Einbeigi Z, et al. No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study. Annals of Oncology. Elsevier BV; 2015; 26:1149-1154 10.1093/annonc/mdv159
• Cosmetic Evaluation Methods Adapted to Asian Patients after Breast-Conserving Surgery and Examination of the Necessarily Elements for Cosmetic Evaluation Cite
  Nohara Y, Hanamura N, Zaha H, Kimura H, Kashikura Y, Nakamura T, et al. Cosmetic Evaluation Methods Adapted to Asian Patients after Breast-Conserving Surgery and Examination of the Necessarily Elements for Cosmetic Evaluation. Journal of Breast Cancer. Korean Breast Cancer Society; 2015; 18:80 10.4048/jbc.2015.18.1.80
• Radiation therapy in the locoregional treatment of triple-negative breast cancer Cite
  Moran MS. Radiation therapy in the locoregional treatment of triple-negative breast cancer. The Lancet Oncology. Elsevier BV; 2015; 16:e113-e122 10.1016/s1470-2045(14)71104-0
• Time Interval From Breast-Conserving Surgery to Breast Irradiation in Early Stage Node-Negative Breast Cancer: 17-Year Follow-Up Results and Patterns of Recurrence Cite
  Vujovic O, Yu E, Cherian A, Dar AR, Stitt L, Perera F. Time Interval From Breast-Conserving Surgery to Breast Irradiation in Early Stage Node-Negative Breast Cancer: 17-Year Follow-Up Results and Patterns of Recurrence. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2015; 91:319-324 10.1016/j.ijrobp.2014.10.006
• Should Women Younger Than 40 Years of Age With Invasive Breast Cancer Have a Mastectomy?: 15-Year Outcomes in a Population-Based Cohort Cite
  Cao JQ, Truong PT, Olivotto IA, Olson R, Coulombe G, Keyes M, et al. Should Women Younger Than 40 Years of Age With Invasive Breast Cancer Have a Mastectomy?: 15-Year Outcomes in a Population-Based Cohort. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014; 90:509-517 10.1016/j.ijrobp.2014.06.041
• Impact of sentinel node tumor burden on outcome of invasive breast cancer patients Cite
  Meattini I, Desideri I, Saieva C, Francolini G, Scotti V, Bonomo P, et al. Impact of sentinel node tumor burden on outcome of invasive breast cancer patients. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2014; 40:1195-1202 10.1016/j.ejso.2014.08.471
• Outcomes of Sentinel Lymph Node Dissection Alone vs. Axillary Lymph Node Dissection in Early Stage Invasive Lobular Carcinoma: A Retrospective Study of the Surveillance, Epidemiology and End Results (SEER) Database Cite
  Wang J, Mittendorf EA, Sahin AA, Yi M, Caudle A, Hunt KK, et al. Outcomes of Sentinel Lymph Node Dissection Alone vs. Axillary Lymph Node Dissection in Early Stage Invasive Lobular Carcinoma: A Retrospective Study of the Surveillance, Epidemiology and End Results (SEER) Database. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e89778 10.1371/journal.pone.0089778
• Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery Cite
  Forget P, Bentin C, Machiels J, Berliere M, Coulie P, De Kock M. Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery. British Journal of Anaesthesia. Elsevier BV; 2014; 113:i82-i87 10.1093/bja/aet464
• Post-operative radiotherapy for ductal carcinoma in situ of the breast Cite
  Goodwin A, Parker S, Ghersi D, Wilcken N. Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database of Systematic Reviews. Wiley; 2013; 10.1002/14651858.cd000563.pub7
• Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial Cite
  van Hezewijk M, Bastiaannet E, Putter H, Scholten AN, Liefers G, Rea D, et al. Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial. Radiotherapy and Oncology. Elsevier BV; 2013; 108:190-196 10.1016/j.radonc.2013.08.020
• Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study Cite
  Sprague BL, McLaughlin V, Hampton JM, Newcomb PA, Trentham-Dietz A. Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2013; 141:145-154 10.1007/s10549-013-2670-3
• Is Ki-67 Expression Prognostic for Local Relapse in Early-Stage Breast Cancer Patients Treated With Breast Conservation Therapy (BCT)? Cite
  Hafeez F, Neboori HJ, Harigopal M, Wu H, Haffty BG, Yang Q, et al. Is Ki-67 Expression Prognostic for Local Relapse in Early-Stage Breast Cancer Patients Treated With Breast Conservation Therapy (BCT)?. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2013; 87:344-348 10.1016/j.ijrobp.2013.05.052
• Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis Cite
  Rakovitch E, Nofech-Mozes S, Narod SA, Hanna W, Thiruchelvam D, Saskin R, et al. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2013; 138:581-590 10.1007/s10549-013-2455-8
• Bilateral reduction mammoplasty following breast cancer: A case-control study Cite
  Cin AD, Knight C, Whelan KF, Farrokhyar F. Bilateral reduction mammoplasty following breast cancer: A case-control study. Canadian Journal of Plastic Surgery. SAGE Publications; 2012; 20:6-9 10.1177/229255031202000105
• Reduction Mammaplasty as a Treatment Option for Early Breast Cancer Cite
  A. Shoeib M, C. Parodi P, Cidollini C. Reduction Mammaplasty as a Treatment Option for Early Breast Cancer. Modern Plastic Surgery. Scientific Research Publishing, Inc.; 2013; 03:15-19 10.4236/mps.2013.31004
• Complete Axillary Lymph Node Dissection Versus Clinical Follow-up in Breast Cancer Patients with Sentinel Node Micrometastasis: Final Results from the Multicenter Clinical Trial AATRM 048/13/2000 Cite
  Solá M, Alberro JA, Fraile M, Santesteban P, Ramos M, Fabregas R, et al. Complete Axillary Lymph Node Dissection Versus Clinical Follow-up in Breast Cancer Patients with Sentinel Node Micrometastasis: Final Results from the Multicenter Clinical Trial AATRM 048/13/2000. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2012; 20:120-127 10.1245/s10434-012-2569-y
• Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy Cite
  Sioshansi S, Ehdaivand S, Cramer C, Lomme MM, Price LL, Wazer DE. Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy. Cancer. Wiley; 2012; 118:3893-3898 10.1002/cncr.27376
• Implanted adipose progenitor cells as physicochemical regulators of breast cancer Cite
  Chandler EM, Seo BR, Califano JP, Andresen Eguiluz RC, Lee JS, Yoon CJ, et al. Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proceedings of the National Academy of Sciences. Proceedings of the National Academy of Sciences; 2012; 109:9786-9791 10.1073/pnas.1121160109
• Comparison of Outcomes of Breast Conserving Therapy in Multifocal and Unifocal Invasive Breast Cancer Cite
  Chung AP, Huynh K, Kidner T, Mirzadehgan P, Sim M, Giuliano AE. Comparison of Outcomes of Breast Conserving Therapy in Multifocal and Unifocal Invasive Breast Cancer. Journal of the American College of Surgeons. Elsevier BV; 2012; 215:137-146 10.1016/j.jamcollsurg.2012.05.006
• Prospective trial of Adipose-Derived Regenerative Cell (ADRC)-enriched fat grafting for partial mastectomy defects: The RESTORE-2 trial Cite
  Pérez-Cano R, Vranckx J, Lasso J, Calabrese C, Merck B, Milstein A, et al. Prospective trial of Adipose-Derived Regenerative Cell (ADRC)-enriched fat grafting for partial mastectomy defects: The RESTORE-2 trial. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2012; 38:382-389 10.1016/j.ejso.2012.02.178
• A Multicenter Investigation of Late Adverse Events in Japanese Women Treated with Breast-conserving Surgery plus Conventional Fractionated Whole-breast Radiation Therapy Cite
  Nozaki M, Kagami Y, Mitsumori M, Hiraoka M. A Multicenter Investigation of Late Adverse Events in Japanese Women Treated with Breast-conserving Surgery plus Conventional Fractionated Whole-breast Radiation Therapy. Japanese Journal of Clinical Oncology. Oxford University Press (OUP); 2012; 42:522-527 10.1093/jjco/hys050
• Ten-Year Risk of Diagnostic Mammograms and Invasive Breast Procedures After Breast-Conserving Surgery for DCIS Cite
  Nekhlyudov L, Habel LA, Achacoso N, Jung I, Haque R, Collins LC, et al. Ten-Year Risk of Diagnostic Mammograms and Invasive Breast Procedures After Breast-Conserving Surgery for DCIS. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2012; 104:614-621 10.1093/jnci/djs167
• Long-Term Outcome in Patients With Ductal Carcinoma In Situ Treated With Breast-Conserving Therapy: Implications for Optimal Follow-up Strategies Cite
  Shaitelman SF, Wilkinson JB, Kestin LL, Ye H, Goldstein NS, Martinez AA, et al. Long-Term Outcome in Patients With Ductal Carcinoma In Situ Treated With Breast-Conserving Therapy: Implications for Optimal Follow-up Strategies. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 83:e305-e312 10.1016/j.ijrobp.2011.12.092
• Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial Cite
  Litière S, Werutsky G, Fentiman IS, Rutgers E, Christiaens M, Van Limbergen E, et al. Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. The Lancet Oncology. Elsevier BV; 2012; 13:412-419 10.1016/s1470-2045(12)70042-6
• Low Frequency of Cancer Occurrence in Same Breast Quadrant Diagnosed with Lobular Neoplasia at Percutaneous Needle Biopsy Cite
  Provencher L, Jacob S, Côté G, Hogue J, Desbiens C, Poirier B, et al. Low Frequency of Cancer Occurrence in Same Breast Quadrant Diagnosed with Lobular Neoplasia at Percutaneous Needle Biopsy. Radiology. Radiological Society of North America (RSNA); 2012; 263:43-52 10.1148/radiol.11111293
• Clinical and pathologic evaluation of implanted free dermal fat grafts after breast cancer surgery: A retrospective analysis Cite
  Kijima Y, Yoshinaka H, Hirata M, Umekita Y, Sohda M, Koriyama C, et al. Clinical and pathologic evaluation of implanted free dermal fat grafts after breast cancer surgery: A retrospective analysis. Surgery. Elsevier BV; 2012; 151:444-455 10.1016/j.surg.2011.07.031
• The Evaluation of Contralateral Breast Lesions in Breast Cancer Patients Using Reduction Mammoplasty Cite
  Dogan L, Gulcelik Ma, Bulut M, Karaman N, Kiziltan G, Ozaslan C. The Evaluation of Contralateral Breast Lesions in Breast Cancer Patients Using Reduction Mammoplasty. Journal of Breast Cancer. Korean Breast Cancer Society; 2011; 14:219 10.4048/jbc.2011.14.3.219
• The role of oncoplastic therapeutic mammoplasty in breast cancer surgery- A review Cite
  Iwuchukwu O, Harvey J, Dordea M, Critchley A, Drew P. The role of oncoplastic therapeutic mammoplasty in breast cancer surgery- A review. Surgical Oncology. Elsevier BV; 2012; 21:133-141 10.1016/j.suronc.2011.01.002
• Improved Outcomes of Breast-Conserving Therapy for Patients With Ductal Carcinoma in Situ Cite
  Halasz LM, Sreedhara M, Chen Y, Bellon JR, Punglia RS, Wong JS, et al. Improved Outcomes of Breast-Conserving Therapy for Patients With Ductal Carcinoma in Situ. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 82:e581-e586 10.1016/j.ijrobp.2011.08.015
• Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation Cite
  Parikh RR, Haffty BG, Lannin D, Moran MS. Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 82:7-13 10.1016/j.ijrobp.2010.08.027
• Accelerated Partial Breast Irradiation Using Brachytherapy for Breast Cancer: Patterns in Utilization and Guideline Concordance Cite
  Hattangadi JA, Taback N, Neville BA, Harris JR, Punglia RS. Accelerated Partial Breast Irradiation Using Brachytherapy for Breast Cancer: Patterns in Utilization and Guideline Concordance. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2011; 104:29-41 10.1093/jnci/djr495
• Change of aesthetic and functional outcome over time and their relationship to quality of life after breast conserving therapy Cite
  Heil J, Czink E, Golatta M, Schott S, Hof H, Jenetzky E, et al. Change of aesthetic and functional outcome over time and their relationship to quality of life after breast conserving therapy. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:116-121 10.1016/j.ejso.2010.11.007
• Widespread Mechanical Pain Hypersensitivity as a Sign of Central Sensitization after Breast Cancer Surgery: Comparison between Mastectomy and Lumpectomy Cite
  Fernández-Lao C, Cantarero-Villanueva I, Fernández-de-las-Peñas C, Del-Moral-Ávila R, Menjón-Beltrán S, Arroyo-Morales M. Widespread Mechanical Pain Hypersensitivity as a Sign of Central Sensitization after Breast Cancer Surgery: Comparison between Mastectomy and Lumpectomy. Pain Medicine. Oxford University Press (OUP); 2011; 12:72-78 10.1111/j.1526-4637.2010.01027.x
• Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1–3 Positive Lymph Nodes? Cite
  Offersen BV, Brodersen H, Nielsen MM, Overgaard J, Overgaard M. Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1–3 Positive Lymph Nodes?. Breast Care. S. Karger AG; 2011; 6:347-351 10.1159/000333250
• Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype Cite
  Lowery AJ, Kell MR, Glynn RW, Kerin MJ, Sweeney KJ. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 133:831-841 10.1007/s10549-011-1891-6
• Cosmetic Outcomes and Complications Reported by Patients Having Undergone Breast-Conserving Treatment Cite
  Hill-Kayser CE, Vachani C, Hampshire MK, Di Lullo GA, Metz JM. Cosmetic Outcomes and Complications Reported by Patients Having Undergone Breast-Conserving Treatment. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 83:839-844 10.1016/j.ijrobp.2011.08.013
• Twenty-five year results of the national cancer institute randomized breast conservation trial Cite
  Simone NL, Dan T, Shih J, Smith SL, Sciuto L, Lita E, et al. Twenty-five year results of the national cancer institute randomized breast conservation trial. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 132:197-203 10.1007/s10549-011-1867-6
• Influence of uncommon histology on breast conservation therapy for breast cancer-biology dictates technique? Cite
  Wasif N, McCullough AE, Gray RJ, Pockaj BA. Influence of uncommon histology on breast conservation therapy for breast cancer-biology dictates technique?. Journal of Surgical Oncology. Wiley; 2011; 105:586-590 10.1002/jso.22132
• Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials Cite
  . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. The Lancet. Elsevier BV; 2011; 378:1707-1716 10.1016/s0140-6736(11)61629-2
• Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation Cite
  Adkins FC, Gonzalez-Angulo AM, Lei X, Hernandez-Aya LF, Mittendorf EA, Litton JK, et al. Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2011; 18:3164-3173 10.1245/s10434-011-1920-z
• Omission of radiation therapy after breast-conserving surgery in the United States Cite
  Tuttle TM, Jarosek S, Habermann EB, Yee D, Yuan J, Virnig BA. Omission of radiation therapy after breast-conserving surgery in the United States. Cancer. Wiley; 2011; 118:2004-2013 10.1002/cncr.26505
• Breast cancer in very young women Cite
  Liukkonen S, Leidenius M, Saarto T, Sjöström-Mattson J. Breast cancer in very young women. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:1030-1037 10.1016/j.ejso.2011.08.133
• Prevalence of lymphoedema more than five years after breast cancer treatment Cite
  Lopez Penha T, Slangen J, Heuts E, Voogd A, Von Meyenfeldt M. Prevalence of lymphoedema more than five years after breast cancer treatment. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:1059-1063 10.1016/j.ejso.2011.09.001
• Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy Cite
  Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, et al. Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:3885-3891 10.1200/jco.2011.36.1105
• Recurrence rates and long-term survival in women diagnosed with breast cancer at age 40 and younger. Cite
  Buckley JM, Coopey S, Samphao S, Specht MC, Hughes KS, Gadd M, et al. Recurrence rates and long-term survival in women diagnosed with breast cancer at age 40 and younger.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:70-70 10.1200/jco.2011.29.27_suppl.70
• Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality? Cite
  Yerushalmi R, Tyldesley S, Woods R, Kennecke H, Speers C, Gelmon K. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?. Annals of Oncology. Elsevier BV; 2011; 23:876-881 10.1093/annonc/mdr326
• Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer Cite
  Vargo JA, Beriwal S, Ahrendt GM, Soran A, Johnson RR, McGuire K, et al. Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer. Oncology. S. Karger AG; 2011; 80:341-349 10.1159/000330203
• Neoadjuvant Chemotherapy Increases the Rate of Breast Conservation in Lobular-Type Breast Cancer Patients Cite
  Fitzal F, Mittlboeck M, Steger G, Bartsch R, Rudas M, Dubsky P, et al. Neoadjuvant Chemotherapy Increases the Rate of Breast Conservation in Lobular-Type Breast Cancer Patients. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2011; 19:519-526 10.1245/s10434-011-1879-9
• Clear margins for invasive lobular carcinoma: A surgical challenge Cite
  Sakr R, Poulet B, Kaufman G, Nos C, Clough K. Clear margins for invasive lobular carcinoma: A surgical challenge. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:350-356 10.1016/j.ejso.2011.01.010
• Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS Cite
  Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, et al. Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2011; 103:478-488 10.1093/jnci/djr027
• Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: A comparison with ECOG study 5194 Cite
  Motwani SB, Goyal S, Moran MS, Chhabra A, Haffty BG. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: A comparison with ECOG study 5194. Cancer. Wiley; 2010; 117:1156-1162 10.1002/cncr.25623
• Effect of Occult Metastases on Survival in Node-Negative Breast Cancer Cite
  Weaver DL, Ashikaga T, Krag DN, Skelly JM, Anderson SJ, Harlow SP, et al. Effect of Occult Metastases on Survival in Node-Negative Breast Cancer. New England Journal of Medicine. Massachusetts Medical Society; 2011; 364:412-421 10.1056/nejmoa1008108
• Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast Cite
  Biglia N, Bounous V, Martincich L, Panuccio E, Liberale V, Ottino L, et al. Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:199-204 10.1016/j.ejso.2010.12.011
• Accurate classification of sentinel lymph node metastases in patients with lobular breast carcinoma Cite
  Apple SK, Moatamed NA, Finck RH, Sullivan PS. Accurate classification of sentinel lymph node metastases in patients with lobular breast carcinoma. The Breast. Elsevier BV; 2010; 19:360-364 10.1016/j.breast.2010.02.010
• The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer Cite
  Gabos Z, Thoms J, Ghosh S, Hanson J, Deschênes J, Sabri S, et al. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 124:187-194 10.1007/s10549-010-1135-1
• Locoregional Recurrence in Patients With Triple-Negative Breast Cancer Cite
  Dragun AE, Pan J, Rai SN, Kruse B, Jain D. Locoregional Recurrence in Patients With Triple-Negative Breast Cancer. American Journal of Clinical Oncology. Ovid Technologies (Wolters Kluwer Health); 2011; 34:231-237 10.1097/coc.0b013e3181dea993
• Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer Cite
  Buist DSM, Abraham LA, Barlow WE, Krishnaraj A, Holdridge RC, Sickles EA, et al. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 124:863-873 10.1007/s10549-010-1106-6
• Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years Cite
  van der Sangen MJC, van de Wiel FMM, Poortmans PMP, Tjan-Heijnen VCG, Nieuwenhuijzen GAP, Roumen RMH, et al. Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 127:207-215 10.1007/s10549-010-1110-x
• Determination of clear margin in breast-conserving surgery: Is 1 mm needed? Cite
  Geffrelot J, Toudic Emily F, Levy C, Blanc Fournier C, Segura C, Switsers O, et al. Determination of clear margin in breast-conserving surgery: Is 1 mm needed?. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:515-515 10.1200/jco.2010.28.15_suppl.515
• Timing of re-excision surgery (S2) for positive margins (PM) and initiation of adjuvant systemic treatment (aRx) in early breast cancer patients (BC pts). Cite
  De Mattos-Arruda L, Rubio I, Garcia-Aceituno L, Cortes J, Sanchez-Olle G, Peg V, et al. Timing of re-excision surgery (S2) for positive margins (PM) and initiation of adjuvant systemic treatment (aRx) in early breast cancer patients (BC pts).. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:e11065-e11065 10.1200/jco.2010.28.15_suppl.e11065
• Conservative surgery in patients with multifocal/multicentric breast cancer Cite
  Gentilini O, Botteri E, Rotmensz N, Da Lima L, Caliskan M, Garcia-Etienne CA, et al. Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2008; 113:577-583 10.1007/s10549-008-9959-7
• The Influence of Margin Width and Volume of Disease Near Margin on Benefit of Radiation Therapy for Women With DCIS Treated With Breast-Conserving Therapy Cite
  Rudloff U, Brogi E, Reiner AS, Goldberg JI, Brockway JP, Wynveen CA, et al. The Influence of Margin Width and Volume of Disease Near Margin on Benefit of Radiation Therapy for Women With DCIS Treated With Breast-Conserving Therapy. Annals of Surgery. Ovid Technologies (Wolters Kluwer Health); 2010; 251:583-591 10.1097/sla.0b013e3181b5931e
• Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10years in early stage breast cancer Cite
  Tanis E, van de Velde C, Bartelink H, van de Vijver M, Putter H, van der Hage J. Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10years in early stage breast cancer. European Journal of Cancer. Elsevier BV; 2012; 48:1751-1756 10.1016/j.ejca.2012.02.051
• Subsets of Women with Close or Positive Margins after Breast Conserving Surgery with High Local Recurrence Risk Despite Breast Plus Boost Radiotherapy Cite
  Truong P, Lupe K, Alexander C, Lesperance M, Tyldesley S. Subsets of Women with Close or Positive Margins after Breast Conserving Surgery with High Local Recurrence Risk Despite Breast Plus Boost Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2010; 78:S52-S53 10.1016/j.ijrobp.2010.07.157
• Avoiding Axillary Treatment in Sentinel Lymph Node Micrometastases of Breast Cancer: A Prospective Analysis of Axillary or Distant Recurrence Cite
  Pernas S, Gil M, Benítez A, Bajen MT, Climent F, Pla MJ, et al. Avoiding Axillary Treatment in Sentinel Lymph Node Micrometastases of Breast Cancer: A Prospective Analysis of Axillary or Distant Recurrence. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2009; 17:772-777 10.1245/s10434-009-0804-y
• Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis Cite
  Punglia RS, Saito AM, Neville BA, Earle CC, Weeks JC. Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis. BMJ. BMJ; 2010; 340:c845-c845 10.1136/bmj.c845
• Breast cancer in women under 40 years of age: A series of 57 cases from Northern Ireland Cite
  McAree B, O'Donnell M, Spence A, Lioe T, McManus D, Spence R. Breast cancer in women under 40 years of age: A series of 57 cases from Northern Ireland. The Breast. Elsevier BV; 2010; 19:97-104 10.1016/j.breast.2009.12.002
• Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes Cite
  Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2010; 102:170-178 10.1093/jnci/djp482
• The importance of the lumpectomy surgical margin status in long term results of breast conservation Cite
  Smitt MC, Nowels KW, Zdeblick MJ, Jeffrey S, Carlson RW, Stockdale FE, et al. The importance of the lumpectomy surgical margin status in long term results of breast conservation. Cancer. Wiley; 1995; 76:259-267 10.1002/1097-0142(19950715)76:2<259::aid-cncr2820760216>3.0.co;2-2
• Mucinous Breast Carcinoma: Occult Multifocality/Multicentricity in a Favorable Disease. Cite
  Perkins G, Babiera G, Bedrosian I, Gonzalez-Angulo A, Whitman G, Yang W, et al. Mucinous Breast Carcinoma: Occult Multifocality/Multicentricity in a Favorable Disease.. Poster Session Abstracts. American Association for Cancer Research; 2009; 10.1158/0008-5472.sabcs-09-4117
• Racial disparities in the use of radiotherapy after breast-conserving surgery: A national Medicare study Cite
  Smith GL, Shih YT, Xu Y, Giordano SH, Smith BD, Perkins GH, et al. Racial disparities in the use of radiotherapy after breast-conserving surgery: A national Medicare study. Cancer. Wiley; 2010; 116:734-741 10.1002/cncr.24741
• Impact of initial surgical margins and residual cancer upon re-excision on outcome of patients with localized breast cancer Cite
  Kouzminova NB, Aggarwal S, Aggarwal A, Allo MD, Lin AY. Impact of initial surgical margins and residual cancer upon re-excision on outcome of patients with localized breast cancer. The American Journal of Surgery. Elsevier BV; 2009; 198:771-780 10.1016/j.amjsurg.2009.05.027
• Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women Cite
  Kouri EM, He Y, Winer EP, Keating NL. Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 121:743-751 10.1007/s10549-009-0643-3
• Factors predicting in-breast tumor recurrence after breast-conserving surgery Cite
  Mechera R, Viehl CT, Oertli D. Factors predicting in-breast tumor recurrence after breast-conserving surgery. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2008; 116:171-177 10.1007/s10549-008-0187-y